PAREXEL
PAREXEL
PAREXEL International is a global provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today.
Revenue(RF), mln.USD
12
Assets(RF), mln.USD
11
Capital(RF), mln.USD
10
Staff(RF), 2021
294
Taxes(RF), mln.USD
3
PAREXEL have 6,000+ staff, with 30+ offices across the region, early phase clinics located in Berlin and London, and clinical trial supplies and logistics depots located in Germany and Russia.
The Company Statement
August 25, 2022
Received revenues in Russia in 2021-2023, there is no any official announcement.
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner